DG
Deepak Goyal
About Deepak Goyal
Data last updated:
Deepak Goyal has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Vitalys Pharmaceuticals Private Limited and Orplis Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vitalys Pharmaceuticals Private Limited at ₹5.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Mar 2023 | 2014 | ₹5.15 Cr (FY 2025) | Active | |
| Director | 04 Aug 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Goyal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Goyal
Deepak Goyal has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Vitalys Pharmaceuticals Private Limited and Orplis Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vitalys Pharmaceuticals Private Limited at ₹5.15 Cr (FY 2025).
Deepak Goyal is associated with 2 companies as Director, including Vitalys Pharmaceuticals Private Limited (₹5.15 Cr), Orplis Pharmaceutical Private Limited.
Deepak Goyal has expertise in General Business.
Deepak Goyal has 4 years in corporate governance.
By reported revenue, the largest current company of Deepak Goyal is Vitalys Pharmaceuticals Private Limited, with revenue of ₹5.15 Cr (FY 2025).
Deepak Goyal currently holds positions at 2 companies: Vitalys Pharmaceuticals Private Limited (₹5.15 Cr), Orplis Pharmaceutical Private Limited.